FRT
58
3
HBI
49
-10
EXC
45
-3
CHK
35
19
REGN
69
4
CVX
35
7
CLX
53
3
RCL
69
-4
DVN
35
6
ALL
48
4
CMCSA
50
-2
AAP
20
-6
KIM
58
7
PSX
57
8
WDC
53
4
ORCL
68
3
TRV
42
-8
LLY
68
-8
DO
60
-2
SWK
64
9
FRT
58
3
HBI
49
-10
EXC
45
-3
CHK
35
19
REGN
69
4
CVX
35
7
CLX
53
3
RCL
69
-4
DVN
35
6
ALL
48
4
CMCSA
50
-2
AAP
20
-6
KIM
58
7
PSX
57
8
WDC
53
4
ORCL
68
3
TRV
42
-8
LLY
68
-8
DO
60
-2
SWK
64
9
Financhill
Back

Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Vs. PTC Therapeutics Industry Stock Comparison

Sell
48

CHAU
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF

Last Price:
13.05
Seasonality Move:
-6.59%
Sell
40

PTCT
PTC Therapeutics

Last Price:
30.41
Seasonality Move:
8.11%
Sell
48
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF (CHAU) is a Sell

Is Direxion Dly CSI 300 CHN A Shr Bl 2X ETF a Buy, Sell or Hold?

  • The current Direxion Dly CSI 300 CHN A Shr Bl 2X ETF [CHAU] share price is $13.05. The Score for CHAU is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CHAU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $31.17. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CHAU Stock Price Chart

What is Direxion Dly CSI 300 CHN A Shr Bl 2X ETF's stock price today?

  • The Direxion Dly CSI 300 CHN A Shr Bl 2X ETF share price today is $13.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHAU is experiencing slight selling pressure.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $31.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.

CHAU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 35.93 Sell
Chaikin Money Flow: -33083 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.23 - 14.17) Sell
Bollinger Bands (100): (13.39 - 14.67) Sell

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 37.27 Sell
Chaikin Money Flow: 51415 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34 - 37.72) Sell
Bollinger Bands (100): (26.7 - 35.2) Buy

CHAU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.09 Sell
20-day SMA: 13.57 Sell
50-day SMA: 14.17 Sell
200-day SMA: 14.18 Sell
8-day EMA: 13.14 Sell
20-day EMA: 13.51 Sell
50-day EMA: 13.88 Sell
200-day EMA: 14.84 Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.02 Sell
20-day SMA: 35.78 Sell
50-day SMA: 33.9 Sell
200-day SMA: 27.61 Buy
8-day EMA: 33.59 Sell
20-day EMA: 34.77 Sell
50-day EMA: 33.84 Sell
200-day EMA: 31.82 Sell

Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Earnings Growth & CHAU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.

Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):